Makoto Bonkobara (M Bonkobara)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Topics

Radical Prostatectomy

Metastatic Colorectal Cancer

Top Venues

Veterinary and comparative oncology

BMC veterinary research

Journal of veterinary pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Masanori Kobayashi, Moe Onozawa, Shiho Watanabe, Tomokazu Nagashima, Kyoichi Tamura, Yoshiaki Kubo, Akiko Ikeda, Kazuhiko Ochiai, Masaki Michishita, Makoto Bonkobara, Masato Kobayashi, Tatsuya Hori, Eiichi Kawakami
Establishment of a BRAF V595E-mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer. Veterinary and comparative oncology (2023)
Masanori Kobayashi, Moe Onozawa, Shiho Watanabe, Tomokazu Nagashima, Kyoichi Tamura, Yoshiaki Kubo, Akiko Ikeda, Kazuhiko Ochiai, Masaki Michishita, Makoto Bonkobara, Masato Kobayashi, Tatsuya Hori, Eiichi Kawakami
Establishment of a BRAF V595E-mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer. Veterinary and comparative oncology (2023)
Hiroyuki Tani, Ryo Miyamoto, Teruki Miyazaki, Shingo Oniki, Kyoichi Tamura, Makoto Bonkobara
A feline case of multiple myeloma treated with bortezomib. BMC veterinary research 18 (1) (2022)
Hiroyuki Tani, Ryo Miyamoto, Syunya Noguchi, Sena Kurita, Tomokazu Nagashima, Masaki Michishita, Naoko Yayoshi, Kyoichi Tamura, Makoto Bonkobara
A canine case of malignant melanoma carrying a KIT c.1725_1733del mutation treated with toceranib: a case report and in vitro analysis. BMC veterinary research 17 (1) (2021)
Hiroyuki Tani, Ryo Miyamoto, Tomokazu Nagashima, Masaki Michishita, Kyoichi Tamura, Makoto Bonkobara
Molecular characterization of canine SHP2 mutants and anti-tumour effect of SHP2 inhibitor, SHP099, in a xenograft mouse model of canine histiocytic sarcoma. Veterinary and comparative oncology (2021)
Hiroyuki Tani, Sena Kurita, Ryo Miyamoto, Kazuhiko Ochiai, Kyoichi Tamura, Makoto Bonkobara
Canine histiocytic sarcoma cell lines with SHP2 p.Glu76Gln or p.Glu76Ala mutations are sensitive to allosteric SHP2 inhibitor SHP099. Veterinary and comparative oncology 18 (2) (2019)
Sena Kurita, Ryo Miyamoto, Hiroyuki Tani, Masato Kobayashi, Takashi Sasaki, Kyoichi Tamura, Makoto Bonkobara
Genetic alterations of KIT during clonal expansion and subsequent acquisition of resistance to toceranib in a canine mast cell tumor cell line. Journal of veterinary pharmacology and therapeutics 42 (6) (2019)
Masaya Igase, Kazuha Shousu, Noriyuki Fujiki, Masashi Sakurai, Makoto Bonkobara, Chung C Hwang, Matt Coffey, Shunsuke Noguchi, Yuki Nemoto, Takuya Mizuno
Anti-tumour activity of oncolytic reovirus against canine histiocytic sarcoma cells. Veterinary and comparative oncology 17 (2) (2019)
K Ito, R Miyamoto, H Tani, S Kurita, M Kobayashi, K Tamura, Makoto Bonkobara
Effect of dasatinib in a xenograft mouse model of canine histiocytic sarcoma and in vitro expression status of its potential target EPHA2. Journal of veterinary pharmacology and therapeutics 41 (1) (2017)